Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Rare gene variants linked to Type 2 diabetes discovered in Asian Indian families

A new study published in Communications Medicine, a Nature publication, details the discovery of rare gene variants that increase the prevalence of Type 2 diabetes in multiple generations of Asian Indian people. The unusual finding is a step toward more target

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

A new study published in Communications Medicine, a Nature publication, details the discovery of rare gene variants that increase the prevalence of Type 2 diabetes in multiple generations of Asian Indian people. The unusual finding is a step toward more targeted treatment for all people with Type 2 diabetes, a disease with complex genetic influences.

"We wanted to study several generations of Asian Indians because understanding genetics in families can give us better information, and Asian Indians have up to six times higher risk of developing Type 2 diabetes than Europeans. In addition, Asian Indians tend to live clustered together and marry within the same caste system," which helped us to identify these rare variants, said lead author Dharambir Sanghera, Ph.D., a professor of pediatric genetics at the University of Oklahoma College of Medicine.

"Our study found that the participants have their own rare gene changes, which aren't found in other unrelated populations around the world," Sanghera added. "This is important because it helps us understand the different causes of diabetes. It also gives us ideas for creating new medications that target specific proteins or pathways. Treating diabetes in a tailored way is important because not everyone responds well to metformin or other medications that lower blood sugar. Moreover, we need to prevent or delay diabetes in children from families who carry many of these gene changes."

When people develop Type 2 diabetes, their genes contribute about 50% to the onset of the disease, and the other 50% is due to lifestyle factors such as poor diet and lack of physical activity. There are three main ways genes can affect diabetes: monogenic, where one gene causes the disease; oligogenic, where a few genes have a big impact, regardless of diet or exercise; and polygenic, where some portion of many genes (over 400) each contribute a small effect, combined with lifestyle factors. Scientists have found these genes by studying millions of people, mostly of European descent. The rare gene variations that Sanghera's team found are an example of oligogenic diabetes, she said.

Sanghera and her team also made an unexpected finding: The gene variants were non-coding. While coding genes are like a "recipe" for building a protein, non-coding gene variants are like "instructions" for when to use the recipe, therefore controlling when and where a protein is made.

Because these families have multiple generations of diabetes, we thought we would discover coding genes because they directly affect a person's susceptibility to diabetes. But by finding rare non-coding variants in a handful of genes correlating strongly with diabetes, we realized this is an example of oligogenic diabetes." Dharambir Sanghera, Ph.D., professor of pediatric genetics, University of Oklahoma College of Medicine

In an incidental finding, the researchers discovered that three of the genes with many rare variations are MODY genes (maturity-onset diabetes in youth). A single MODY gene can cause diabetes (monogenic) no matter how healthy a person's lifestyle is, Sanghera said. There are about 14 MODY genes that cause this kind of diabetes in young adults, but their link to Type 2 diabetes isn't well understood.

"These findings suggest we need to study the role of MODY genes in Type 2 diabetes more closely by looking at the genes of families affected by it," Sanghera said. "The most interesting part of this study was that families with many cases of late-onset Type 2 diabetes and a number of rare non-coding gene changes had fewer common genetic risk factors, known as the 'polygenic risk score.' Usually, people with higher polygenic scores have more rare genetic changes.

"The genetic component of diabetes is very complex because the condition is so heterogeneous (has several root causes), just like there are several types of breast cancer and different treatments based on the subtypes of breast cancer," Sanghera added. "The more we understand about the genetics of diabetes, the closer we move to precision medicine – treating people according to the specific type of diabetes that they have."

Rout, M., et al. (2025). Excess of rare noncoding variants in several type 2 diabetes candidate genes among Asian Indian families. Communications Medicine. doi.org/10.1038/s43856-025-00750-9.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01Please can you give an overview of the current drug discovery paradigm? In what ways do you think it needs to be leaner?

With the current drug discovery paradigm, it takes up to 15 years to translate an idea, such as hypothesizing a certain protein is important in a disease and testing this with targeting the protein with a drug, all the way through to proof of concept. The drug has to be filed with the regulatory authorities, having done all the safety and efficacy testing. It's a long process and it's also very costly. Estimates vary, but it's currently reckoned to cost over 1 billion dollars per drug. That’s partly because you have to pay for all the drugs that didn't make it. By the time you've taken a protein target and you've made a whole load of molecules that affect that target in the way you want them to, you've probably already spent a couple of years on it and then you have to take the best molecule through the appropriate safety testing in animals before proceeding to phase 1 testing in people. Even if you get to phase 1 testing, where you are just giving it to human volunteers for the first time, not even patients, about 95% of the compounds at the stage then fail to make it all the way through to the market. So, you’ve only got a 5% success rate. The odds are not good and, essentially, it is why so many companies have had to merge because, over time, this is becoming less and less sustainable as a business model.

Source: www.news-medical.net ↗
02What supplements really work?

The bulk of vitamins and supplements containing fish oil, biotin, and vitamins A, C, and E can potentially promote nail and hair growth. You can find dietary supplements with higher concentrations of vitamins and minerals that aid skin, hair, and nail health. Fish oil supplements make nails and hair shiny. Fish oil also serves as an agent that can decrease signs of aging. If sun exposure damages the skin, the omega-3 fatty acids in fish oil can help. Biotin, also known as B7, increases hair density and strengthens it. It is found naturally in bananas, eggs, and milk. Vitamins are vital for skin health as well. Vitamin A reduces acne flairs and helps with changes due to aging like wrinkling. A vitamin A deficiency may increase the risk of acne because it becomes difficult for dead skin to slough off hair follicles, blocking pores. Vitamin B lowers the risk of precancerous growths and nonmelanoma skin cancer. Vitamin C is an antioxidant. It leads the fight against free radicals to help stimulate collagen and brighten skin. It also helps to prevent the formation of unneeded melanin that causes uneven skin pigmentation.

Source: www.medicinenet.com ↗
03Why are these clinical trial results so groundbreaking?

There are no targeted treatments approved for pancreas cancer, and we haven't had any significant progress for a long time. We've only come up with different chemotherapy combinations, and those are only moderately effective. This new treatment is staggeringly better than chemotherapy. Usually, when we think of an improvement in pancreatic cancer survival, we think of 25% improvement. This medication actually doubled survival in patients with advanced disease. We have patients who participated in the trial who are still alive, which is unheard of because the five-year survival rate for pancreatic cancer patients is only 13%-14%. If the drug is approved by the FDA, it will most likely become the new standard of care for advanced pancreatic cancer and could replace chemotherapy as a first-line treatment.

Source: www.news-medical.net ↗
04You have worked across the full drug development pipeline. How has that experience shaped your view of where AI can have the greatest impact in drug safety discovery?

Having worked across different parts of the discovery process, I think broad exposure changes the way you think. I have developed quantum chemistry, artificial intelligence (AI) and machine learning (ML) methods in research settings, but I have also had the chance to apply them in real discovery environments for materials and pharmaceuticals. That experience has shown me how different parts of the discovery pipeline interact, what their motivations are, and how they communicate. AI and ML have been used in early discovery for many years, but the biggest recent shift is in areas dominated by human processes and communication. Computers can now interact directly with human language and analytical images, opening new applications such as AI research assistants and AI-assisted dossier drafting. That means AI can start to work more collaboratively with scientists, although expert oversight and guardrails remain essential. In nonclinical safety, I think the biggest impact will be AI working alongside safety scientists to unearth key data, connect safety science with earlier discovery and later clinical work, and help process, predict, and summarize important outcomes. That could help safety science integrate more tightly with design, make, and test cycles in discovery, while also interfacing earlier with clinical science. Save a Copy of This Exclusive Interview by Downloading the Free PDF

Source: www.news-medical.net ↗
05What are carbs?

Your weight loss plan should keep you healthy and strong as you lose the extra weight. Many plans include a diet low in carbohydrates. Carb cycling is a method of optimizing your carbohydrate intake to meet your needs while dieting, fasting, and working out. When you're carb cycling, you consume carbs to meet your needs on some days and avoid them on other days. The aim of carb cycling is to consume carbohydrates when your body needs them and exclude them at other times. Such strategies in your diet plan can help your weight loss efforts. Carbohydrates, or carbs, are a significant part of the average human diet. Along with proteins and fats, they make up the bulk of your daily meals. Most carbohydrates are broken down by your body into glucose to provide energy for your cells and tissues. Carbohydrates in your diet are of three types — sugars, starches, and fiber. Sugars are simple carbs. Glucose, sugar (sucrose), lactose found in milk, and fructose found in fruits, are naturally occurring sugars. Your body metabolizes these molecules rapidly to yield energy. Starches are complex carbs. They're large molecules that consist of hundreds of molecules of simple sugars joined together. Your body needs to break them down to release energy. Starches are found in bread, potatoes, peas, corn, cereals, and pasta. Fiber is also a complex carbohydrate. Human bodies can't break down these large molecules, so they provide no energy. They're usually excreted as they are in the feces. They add bulk to your meal, so you feel full. Fiber in the diet helps avoid constipation and lowers blood sugar and cholesterol levels. Carbohydrates are an essential part of your diet. A typical diet provides 45% to 65% of its calories from carbohydrates. If you have 2,000 calories a day, you should have about 275 grams of carbohydrates. Always try to choose healthy foods for your carb intake:

Source: www.medicinenet.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →